These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30974091)

  • 1. Quantitative Dot Blot (QDB) as a universal platform for absolute quantification of tissue biomarkers.
    Zhang W; Yu G; Zhang Y; Tang F; Lv J; Tian G; Zhang Y; Liu J; Mi J; Zhang J
    Anal Biochem; 2019 Jul; 576():42-47. PubMed ID: 30974091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a routine lab test for absolute quantification of HER2 in FFPE breast cancer tissues using Quantitative Dot Blot (QDB) method.
    Yu G; Zhang W; Zhang Y; Lv J; Wu S; Sui X; Zhang J; Tang F
    Sci Rep; 2020 Jul; 10(1):12502. PubMed ID: 32719400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients.
    Yu G; Lyu Y; Jiang L; Wang Y; Yin Y; Zhang J; Yang M; Tang F
    Front Oncol; 2023; 13():920698. PubMed ID: 36969021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method.
    Hao J; Lyu Y; Zou J; Zhang Y; Xie S; Jing L; Tang F; Lyu J; Zhang W; Zhang J; Wang X; Chen K; Zhang J
    Front Oncol; 2021; 11():737781. PubMed ID: 34604077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB).
    Zhu Y; Qi X; Yu C; Yu S; Zhang C; Zhang Y; Liu X; Xu Y; Yang C; Jiang W; Tian G; Li X; Bergquist J; Zhang J; Wang L; Mi J
    Clin Proteomics; 2019; 16():12. PubMed ID: 30988666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of absolutely quantitated Ki67 and cyclinD1 protein levels for prognosis of Luminal-like breast cancer patients.
    Yu G; Lyu J; Li Y; Zhang Y; Lyu Y; Zhang W; Zhang J; Cai B; Zhang J; Tang F
    J Clin Lab Anal; 2022 Aug; 36(8):e24601. PubMed ID: 35819123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective Quantitation of EGFR Protein Levels using Quantitative Dot Blot Method for the Prognosis of Gastric Cancer Patients.
    Xin L; Tang F; Song B; Yang M; Zhang J
    J Gastric Cancer; 2021 Dec; 21(4):335-351. PubMed ID: 35079437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
    Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
    Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis (QDB).
    Qi X; Zhang Y; Zhang Y; Ni T; Zhang W; Yang C; Mi J; Zhang J; Tian G
    J Vis Exp; 2018 Aug; (138):. PubMed ID: 30199009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.
    Thomas MD; McIntosh GG; Anderson JJ; McKenna DM; Parr AH; Johnstone R; Lennard TW; Horne CH; Angus B
    J Clin Pathol; 1997 Feb; 50(2):143-7. PubMed ID: 9155696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.
    Neely C; You S; Mendoza PM; Aneja R; Sahin AA; Li X
    Breast J; 2018 Nov; 24(6):889-893. PubMed ID: 30230095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The line blot assay: problems with titrating first and second antibodies for Western blot and immunohistochemistry assays?
    Rojas-Espinosa O; Silva-Miranda M; Wek-Rodriguez K; Arce-Paredes P
    Scand J Clin Lab Invest; 2006; 66(4):357-62. PubMed ID: 16777764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant.
    Robertson S; Rönnlund C; de Boniface J; Hartman J
    Breast Cancer Res Treat; 2019 Apr; 174(3):795-805. PubMed ID: 30659433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Fidelity of Breast Biomarker Metrics: A 10-Year Experience in a Single, Large Academic Institution.
    Zhang H; Han M; Varma KR; Clark BZ; Bhargava R; Dabbs DJ
    Appl Immunohistochem Mol Morphol; 2018; 26(10):697-700. PubMed ID: 30095467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative immunoassay for lung cancer biomarker CIZ1b in patient plasma.
    Coverley D; Higgins G; West D; Jackson OT; Dowle A; Haslam A; Ainscough E; Chalkley R; White J
    Clin Biochem; 2017 Apr; 50(6):336-343. PubMed ID: 27867087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative dot blot analysis (QDB), a versatile high throughput immunoblot method.
    Tian G; Tang F; Yang C; Zhang W; Bergquist J; Wang B; Mi J; Zhang J
    Oncotarget; 2017 Aug; 8(35):58553-58562. PubMed ID: 28938578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.
    Milde-Langosch K; Bamberger AM; Rieck G; Kelp B; Löning T
    Breast Cancer Res Treat; 2001 May; 67(1):61-70. PubMed ID: 11518467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018.
    Stevanovic L; Choschzick M; Moskovszky L; Varga Z
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2983-2994. PubMed ID: 31628534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis.
    Gándara-Cortes M; Vázquez-Boquete Á; Fernández-Rodríguez B; Viaño P; Ínsua D; Seoane-Seoane A; Gude F; Gallego R; Fraga M; Antúnez JR; Curiel T; Pérez-López E; García-Caballero T
    Virchows Arch; 2018 Feb; 472(2):195-203. PubMed ID: 28825136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of two ELISA for estrogen and progesterone receptor with sufficient sensitivity for fine needle aspirate and core biopsy.
    Sun CF; Wu TL; Tsao KC; Wu JT
    J Clin Lab Anal; 2001; 15(3):138-43. PubMed ID: 11344529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.